Impact Biomedical (IBO) Market Capitalization (2024 - 2026)

Impact Biomedical (IBO) has reported Market Capitalization for 3 consecutive years, with $49.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization rose 526.19% year-over-year to $49.6 million; the trailing twelve-month figure through Jun 2026 stood at $49.6 million (up 526.19% YoY), and the FY2025 full-year result was $15.8 million, down 5.43% from the prior year.
• Market Capitalization slipped to $49.6 million in Q2 2026 per IBO's latest filing, from $64.7 million in the prior quarter.
• Across five years, Market Capitalization topped out at $64.7 million in Q1 2026 and bottomed at $7.9 million in Q2 2025.
• Historically, Market Capitalization has averaged $24.5 million across 3 years, with a median of $16.2 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Market Capitalization plunged 64.52% in 2025, then soared 526.19% in 2026.
• Over 3 years, Market Capitalization stood at $16.7 million in 2024, then decreased by 5.43% to $15.8 million in 2025, then jumped by 214.4% to $49.6 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $49.6 million, $64.7 million, and $15.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.